Chevron Corp vs Health Care Select Sector SPDR Fund — how do they compare? Chevron Corp trades at $211.98 (market cap $414.98B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Chevron Corp is far larger — about 9.5× Health Care Select Sector SPDR Fund's market cap, and Chevron Corp pays a 3.37% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Chevron Corp for 101 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| CVX | XLV | |
|---|---|---|
Market Cap | $414.98B | $43.48B |
Volume | 7,575,112 | 11,121,431 |
Sector | Energy | — |
52-Week High | $217.73 | $175.68 |
52-Week Low | $146.72 | $141.95 |
Typical Hold Time | 101 Days | 100 Days |
Enterprise Value | $443.52B | — |
Dividend Yield | 3.37% | — |
Signals from Pluang's Aura AI — not financial advice
CVX trades at $211.605, up 3.13% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock is supported by robust cash flow from operations of $33.94B in 2025 and a dividend of $1.78 per share. However, revenue and net income have declined from 2022 peaks, with 2025 revenue at $184.43B and net income at $12.30B. Analyst consensus is bullish with a $208.31 price target, though geopolitical tensions and oil price volatility pose risks.
The outlook for CVX is cautiously optimistic, driven by high oil prices and strategic investments like the $13.8B Argentina project. Investment opportunities include a solid dividend yield and potential upside from production growth. Key risks are exposure to fluctuating oil prices, geopolitical instability affecting supply chains, and declining profit margins. Investors should weigh strong cash generation against cyclical industry pressures.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →